What is the active ingredient of this solution?

The active ingredient is 45%-55% Citric Acid.

Nice Price and High Quality 50% Citric Acid Disinfection Solution for Hemodialysis Machine

Name: Nice Price and High Quality 50% Citric Acid Disinfection Solution for Hemodialysis Machine
Brand: Shandong Retouch Wash and Sterilize Technology Co., Ltd.
SKU: 2045102942

Shandong, ChinaShandong Retouch Wash and Sterilize Technology Co., Ltd.

US$10.00

1,000 Pieces

Sample price:US$10.00/piece.Request sample

Product profile

Customization

Available

Type

Disinfectant

Active Ingredient

45%-55% Citric Acid

Efficacy

Effiective

Uses

Hemodialysis Machine Cleaning

Sample

Sample Offered

Logo

Logo Can Custom

Transport Package

Barrels in Cartons

Specification

5L/barrel

Trademark

Retouch

Origin

China

HS Code

2918140000

Production Capacity

30000pieces/Day

Key features

Cross-Infection Prevention: Prevents cross infection during hemodialysis treatment using citric acid solution.

Customizable Logo: Logo can be customized for branding purposes.

OEM Service Available: We provide OEM service for customized designs and packaging.

ISO9001 Certified: Company passed ISO9001:2008 quality management system certification.

Free Sample Offered: Samples are provided free of charge; customer bears shipping cost.

100% Quality Responsibility: We take 100% responsibility for product quality issues.

Fast Production Lead Time: Peak and off-season lead time is within 15 workdays.

Company profile

High Repeat Buyers ChoiceImporters and ExportersSelf-brandedNational Award received

Shandong Retouch Wash and Sterilize Technology Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 7 Years CertifiedNearest Port: Qingdao PortAverage Response Time: ≤8.44h

AI-Powered supplier vetting

SummaryThe supplier operates in medical devices, hygiene products, disinfectants, personal hygiene products, and related import/export activities. It reports production and sales capabilities covering Class I–III medical devices, although the provided business-scope records include both licensed and general project descriptions that should be verified. The supplier has documented procedures for complaints, corrective and preventive actions, finished-product inspection, and supplier assessment. It offers extensive customization and ODM/OEM services, holds CE-related certification, and has an available SDK. Export activity has continued for seven years, with self-operated import/export rights and stated peak- and off-season lead times within 15 working days. However, it reports no overseas warehouse or showroom, no new product in the past year, no Fortune 500 cooperation, and only five R&D engineers. Financial records are referenced for multiple years, but the slices provide no performance figures.

Supplier typeThe supplier’s stated scope covers medical-device production and sales, hygiene and disposable medical products, disinfectants, personal hygiene products, hazardous-chemical operations, and import/export activities. The records include Class I–III medical-device activities, but the exact current authorization status should be verified because the scope entries distinguish licensed projects from general projects.

CertificationsThe supplier reports CE certification for product compliance and sustainable development/product certification capability, along with other management-system and raw-material-report certifications. CE is explicit, while the unspecified “Others” entries do not identify additional standards or certification names.

After-Sales capabilityThe supplier has clear procedures and followed records for corrective and preventive actions and customer complaints, plus written and followed procedures for finished-product inspection and supplier-service assessment. These records support an organized service and quality-response process, although no specific response-time or resolution-performance metrics are provided.

Production capacityProduction capability is supported by stated Class I–III medical-device activities, valid manufacturing contracts with associated subcontractors, in-stock capability, inspection instructions that are uniformly followed, 80 qualified service-capability suppliers, and lead times within 15 working days in both peak and off-season. The supplier lacks overseas warehouse and showroom capability, which limits geographic service infrastructure but does not negate its reported manufacturing capacity.

Customization capabilityThe supplier explicitly offers customization from samples, designs, full customization, minor customization, flexible customization, and ODM services. This indicates broad customization coverage across both customer-provided inputs and supplier-led design/manufacturing.

Client casesThe supplier reports OEM service for well-known brands and a repeat-buyer preference rate of 50%–80%, providing evidence of brand-serving and repeat-customer experience. It also explicitly reports no cooperation with Fortune 500 companies, and no named customer cases are supplied.